Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis.

Judit Zsuga,János Török,Mária Tünde Magyar,Attila Valikovics,Rudolf Gesztelyi,Sándor Kéki,László Csiba,Miklós Zsuga,Dániel Bereczki

Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis.

2007

Judit Zsuga
János Török
Mária Tünde Magyar
Attila Valikovics
Rudolf Gesztelyi
Sándor Kéki
László Csiba
Miklós Zsuga
Dániel Bereczki

Background: Asymmetric dimethylarginine (ADMA) assumes a significant role in atherosclerosis by inhibiting the endothelial nitric oxide synthase (eNOS). Moreover, ADMA inhibits the

Keywords:

Inflammation
Intima-media thickness
Nitric oxide synthase
Internal medicine
Vascular disease
Cardiology
Asymmetric dimethylarginine
Common carotid artery
Internal carotid artery
Medicine
Enos
Diabetes mellitus
early onset
endothelial nitric oxide synthase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations